Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

JSE/XII stock hub

JSE/XII has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

JSE/XIIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

183.4M

Johannesburg Stock Exchange

Market data

Price

Recent price action with selectable time range.

JSE/XIIJSE/XII

—

Loading chart…

In the news

Latest news · JSE/XII

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E446.4

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC9.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All JSE/XII market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

172

Groups with data

Currency

USD

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Mauritius
Country code	ZA
Enterprise value	ZAc 247.9M
Exchange	Johannesburg Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	MU0810N00005
Last refreshed	2026-05-10
Market cap	ZAc 183.4M
Price	ZAc 32
Price currency	ZAc
Sector	Healthcare
Sic	8090
Symbol	jse/XII
Website	https://numeral.co.za

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.22%
EV Earnings	603.4x
EV/EBIT	34.55x
EV/FCF	-5.85x
EV/Sales	4.84x
FCF yield	-23.11%
P/B ratio	-5.44x
P/E ratio	446.45x
P/S ratio	3.43x
PE Ratio3 Y	148.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.02%
Gross margin	75.62%
Gross Profit	ZAc 40.4M
Gross Profit Growth	350.5%
Gross Profit Growth Q	88.28%
Gross Profit Growth3 Y	247.74%
Gross Profit Growth5 Y	-8.56%
Net Income	ZAc 410,846
Net Income Growth	-94.72%
Net Income Growth Q	-66.96%
Net Income Growth Years	5%
Net Income Growth5 Y	-36.77%
Pretax Margin	6.81%
Profit Margin	0.77%
Profitable Years	2
ROA	11.75
Roa5y	-17,134.2
ROCE	13.88
ROIC	9.19

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	220.26%
Cagr3y	47.35%
Cagr5y	1.3%
EPS Growth	-95.77
EPS Growth Q	-66.96
EPS Growth Years	5
EPS Growth5 Y	-40.72
Revenue Growth	548.23x
Revenue Growth Q	174.31x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	281.68x
Revenue Growth5 Y	-6.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ZAc 1.34
Assets	ZAc 61.3M
Cash	ZAc 2.2M
Current Assets	ZAc 25.5M
Current Liabilities	ZAc 7M
Debt	ZAc 87.7M
Debt FCF	ZAc -2.07
Equity	ZAc -33.7M
Liabilities	ZAc 95M
Long Term Assets	ZAc 35.8M
Long Term Liabilities	ZAc 88M
Net Cash	ZAc -85.5M
Net Cash By Market Cap	ZAc -46.64
Tangible Book Value	ZAc -15.5M
Tangible Book Value Per Share	ZAc -1.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.66
Net Working Capital	ZAc 17.2M
Quick ratio	3.13
Working Capital	ZAc 19.3M
Working Capital Turnover	ZAc 61.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-24.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	220%
200-day SMA	22.33
3Y total return	220%
50-day SMA	36.88
50-day SMA vs 200-day SMA	50over200
5Y total return	6.67%
All Time High	800
All Time High Change	-96%
All Time High Date	2017-09-26
All Time Low	5
All Time Low Change	540%
All Time Low Date	2026-01-28
ATR	0.78
Ch YTD	60
High	32
High52	40
High52 Date	2026-04-02
High52ch	-20%
Low	32
Low52	5
Low52 Date	2026-01-28
Low52ch	540%
Ma50ch	-13.23%
Price vs 200-day SMA	43.34%
RSI	25.95
RSI Monthly	55.67
RSI Weekly	55.93
Sharpe ratio	1.4x
Sortino ratio	4.05
Total Return	-24.92%
Tr YTD	60
Tr1m	-8.57%
Tr3m	-17.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ZAc 7.5M
Operating Income Growth	-5.35
Operating Income Growth Q	-54.99
Operating Income Growth5 Y	-12.45
Operating margin	14.02

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	26,023,292%
Net Borrowing	49,339,241.7
Shares Insiders	6.44%
Shares Qo Q	0%
Shares Yo Y	24.92%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ZAc -42.4M
Average Volume	2,894.25x
Bv Per Share	-1.25
CAPEX	ZAc -8.8M
Ch1m	-8.57
Ch1y	220
Ch3m	-17.95
Ch3y	220
Ch5y	6.67
Ch6m	60
Change	0%
Change From Open	0
Close	32
Days Gap	0
Depreciation Amortization	6,703,817.9
Dollar Volume	151,040
Earnings Date	2026-05-31
EBIT	ZAc 7.5M
EPS	ZAc 0.03
F Score	4
FCF	ZAc -42.4M
FCF EV Yield	-17.1x
Financing CF	41,744,557
Fiscal Year End	February
Founded	2,010
Income Tax	ZAc 1.5M
Investing CF	-8,304,806
Is Primary Listing	0
Last Earnings Date	2026-01-15
Last Report Date	2025-11-30
Last Split Date	2026-01-28
Last Split Type	Reverse
Lynch Fair Value	ZAc 0.36
Lynch Upside	-98.88
Ma150	25.3
Ma150ch	26.48%
Ma20	34.25
Ma20ch	-6.57%
Net CF	-105,914
Next Earnings Date	2026-05-31
Open	32
Ppne	2,312,561.7
Price Date	2026-05-04
Relative Volume	1.63x
Revenue	53,430,590x
Tax By Revenue	2.73x
Tax Rate	40.04%
Tr6m	60%
Volume	4,720
Z Score	-8.14

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does JSE/XII pay a dividend?

Capital-return profile for this ticker.

Performance

JSE/XII stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns JSE/XII?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+6.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+24.9%

Negative means the company is buying back shares.

Technical

JSE/XII momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

26.0

Below 30: short-term oversold

Price vs 200-day MA

+43.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About JSE/XII

Hub-level FAQ points readers to the deeper analysis pages.

What is the current jse/XII stock rating?

jse/XII is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full jse/XII analysis?

The full report lives at /stocks/jse/XII/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for jse/XII?

The latest report frames jse/XII around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the jse/XII page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.